Inari Medical Quick Ratio 2019-2024 | NARI
Historical quick ratio values for Inari Medical (NARI) over the last 10 years.
| Inari Medical Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-03-31 | $0.19B | $0.09B | 2.19 |
| 2023-12-31 | $0.19B | $0.08B | 2.52 |
| 2023-09-30 | $0.43B | $0.07B | 6.49 |
| 2023-06-30 | $0.41B | $0.06B | 6.97 |
| 2023-03-31 | $0.39B | $0.05B | 8.05 |
| 2022-12-31 | $0.39B | $0.06B | 6.95 |
| 2022-09-30 | $0.38B | $0.04B | 9.00 |
| 2022-06-30 | $0.39B | $0.04B | 9.39 |
| 2022-03-31 | $0.39B | $0.04B | 10.95 |
| 2021-12-31 | $0.22B | $0.04B | 5.27 |
| 2021-09-30 | $0.21B | $0.03B | 7.07 |
| 2021-06-30 | $0.21B | $0.03B | 6.65 |
| 2021-03-31 | $0.21B | $0.02B | 10.07 |
| 2020-12-31 | $0.20B | $0.01B | 14.10 |
| 2020-09-30 | $0.19B | $0.01B | 13.42 |
| 2020-06-30 | $0.21B | $0.01B | 19.64 |
| 2020-03-31 | $0.00B | 0.00 | |
| 2019-12-31 | $0.00B | 0.00 | |
| 2019-09-30 | $0.00B | 0.00 | |
| 2019-06-30 | $0.00B | 0.00 | |
| 2018-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.441B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.054B | 26.42 |
| Intuitive Surgical (ISRG) | United States | $133.955B | 80.69 |
| Edwards Lifesciences (EW) | United States | $51.257B | 33.36 |
| DexCom (DXCM) | United States | $50.367B | 76.29 |
| IQVIA Holdings (IQV) | United States | $40.318B | 23.48 |
| IDEXX Laboratories (IDXX) | United States | $39.297B | 46.06 |
| Alcon (ALC) | Switzerland | $38.669B | 28.52 |
| STERIS (STE) | Ireland | $20.379B | 24.12 |
| Waters (WAT) | United States | $18.717B | 26.86 |
| Hologic (HOLX) | United States | $17.818B | 19.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.032B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.711B | 15.70 |
| ShockWave Medical (SWAV) | United States | $12.378B | 85.27 |
| Sysmex ADR (SSMXY) | Japan | $10.769B | 33.77 |
| Teleflex (TFX) | United States | $9.360B | 14.57 |
| Penumbra (PEN) | United States | $7.986B | 98.59 |
| Masimo (MASI) | United States | $7.209B | 40.43 |
| Globus Medical (GMED) | United States | $6.834B | 21.67 |
| Glaukos (GKOS) | United States | $5.271B | 0.00 |
| TransMedics (TMDX) | United States | $4.071B | 388.88 |
| Integer Holdings (ITGR) | United States | $3.683B | 22.25 |
| LivaNova (LIVN) | United Kingdom | $3.407B | 20.23 |
| PROCEPT BioRobotics (PRCT) | United States | $3.173B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.695B | 18.49 |
| Nihon Kohden (NHNKY) | Japan | $2.459B | 20.80 |
| Tandem Diabetes Care (TNDM) | United States | $2.360B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.260B | 9.27 |
| RxSight (RXST) | United States | $2.206B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.847B | 0.00 |
| Veracyte (VCYT) | United States | $1.543B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.911B | 18.08 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| Artivion (AORT) | United States | $0.847B | 97.86 |
| Paragon 28 (FNA) | United States | $0.810B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.757B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.745B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.661B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.612B | 20.76 |
| SiBone (SIBN) | United States | $0.602B | 0.00 |
| IRadimed (IRMD) | United States | $0.555B | 31.10 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.495B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.479B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.445B | 0.00 |
| Nevro (NVRO) | United States | $0.409B | 0.00 |
| NeuroPace (NPCE) | United States | $0.399B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.343B | 11.55 |
| Sight Sciences (SGHT) | United States | $0.278B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.272B | 0.00 |
| AxoGen (AXGN) | United States | $0.257B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.244B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.186B | 10.05 |
| CVRx (CVRX) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.153B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.151B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.109B | 0.00 |
| Neuronetics (STIM) | United States | $0.105B | 0.00 |
| Envoy Medical (COCH) | United States | $0.095B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 128.67 |
| Autonomix Medical (AMIX) | United States | $0.061B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.059B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.059B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |